A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism

Abstract

TLANDO restored testosterone levels to the normal range in the majority of hypogonadal males. This new oral testosterone replacement therapy can provide an option for no-titration oral testosterone replacement therapy. This therapy has the potential to improve patient compliance in testosterone replacement therapy.